Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer

Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in... J Cancer Res Clin Oncol (2017) 143:1713–1732 DOI 10.1007/s00432-017-2421-7 ORIGINAL ARTICLE – CANCER RESEARCH Dual activation of Toll‑like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer 1 1,2 3 1 Mariela A. Moreno Ayala · María Florencia Gottardo · María Soledad Gori · Alejandro Javier Nicola Candia · 1,2 4,5 1 6 2,6 Carla Caruso · Andrea De Laurentiis · Mercedes Imsen · Slobodanka Klein · Elisa Bal de Kier Joffé · 3,7 8,9 1,2 1 Gabriela Salamone · Maria G. Castro · Adriana Seilicovich · Marianela Candolfi Received: 30 April 2016 / Accepted: 8 April 2017 / Published online: 21 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract simultaneously activated. Blockade of nitric oxide synthase Purpose Since combination of Toll-like receptor (TLR) (NOS) and indoleamine-pyrrole-2,3-dioxygenase (IDO) ligands could boost antitumor immunity, we evaluated the improved the activation of CpG-DCs. When we evaluated efficacy of dendritic cell (DC) vaccines upon dual activa - the effect of combined activation of TLR9 and TLR7 in tion of TLR9 and TLR7 in breast cancer models. human DCs, we found that R848 induced robust DC activa- Methods DCs were generated from mouse bone marrow http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Loading next page...
 
/lp/springer_journal/dual-activation-of-toll-like-receptors-7-and-9-impairs-the-efficacy-of-K4MLyQFx8z
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2421-7
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial